Effector binding by Bacillus subtilit CodY
枯草芽孢杆菌 CodY 的效应子结合
基本信息
- 批准号:7484169
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2008-11-03
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAmino AcidsBacillus (bacterium)Bacillus subtilisBacteriaBacterial InfectionsBindingBiochemicalBiological AssayBranched-Chain Amino AcidsCellsChromosomesCircular DichroismCrystallographyDNADNA BindingDNase-I FootprintingDevelopmentDisruptionEssential Amino AcidsFluorescence SpectrometryGTP BindingGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGoalsGram-Positive BacteriaGuanosine TriphosphateIn VitroIsoleucineMicroarray AnalysisMolecularMutationNutrientPhysiologicalProteinsProteolysisRegulationReporterSite-Directed MutagenesisSpectroscopy, Fourier Transform InfraredStarvationStructureVirulence FactorsWorkantimicrobialbasedetection of nutrientnovelpathogenresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Bacillus subtilis employs several adaptive strategies when faced with nutrient limitation. Expression of many of these adaptive mechanisms is under regulation by CodY, a highly conserved protein in Gram-positive bacteria. CodY senses nutrient availability by interaction with its effectors, GTP and the branched-chain amino acids (BCAAs). Upon effector binding, CodY is able to bind to and repress its DNA targets. It is uncertain which amino acids in CodY are necessary for interaction with these effectors, and it is unclear how effector binding alters CodY such that it interacts with DNA. The goal of this project is to address both of these underlying questions. As CodY has been shown to regulate expression of virulence factors in several bacterial pathogens, it is an attractive target for novel antimicrobial therapy. However, development of this line of therapy will require examination of these basic issues concerning CodY activity. The first aim of this application will identify amino acids essential for effector binding. Homology searches and x-ray crystallography studies have yielded some clues about which CodY residues may be important for GTP and BCAA binding, respectively. These residues will be mutagenized, and their impact on effector binding will be determined. The second aim of this application will investigate how effector binding increases CodY's affinity for DNA. Partial proteolysis has indicated that a conformational change occurs in CodY upon binding to BCAAs, but no change was observed upon CodY binding to GTP. Near-UV circular dichroism, spectrofluorometry, and Fourier transform infrared spectroscopy will be used to identify whether GTP induces a subtle alteration in the tertiary structure of CodY. Experiments in the third aim will assess the physiological impact of the loss of CodY effector binding on gene expression. These codY mutations will be introduced into the B. subtilis chromosome, and their effects will be assayed by reporter fusion experiments and microarray analysis. The results of this work will allow us to understand how bacteria regulate gene expression in response to nutrient starvation. Disruption of this regulation may result in a novel means of treatment of certain bacterial infections.
描述(由申请人提供):面对营养限制时,枯草芽孢杆菌采用了几种自适应策略。这些自适应机制的许多表达受到革兰氏阳性细菌中高度保守的蛋白质Cody的调节。 Cody通过与其效应子GTP和分支链氨基酸(BCAA)相互作用来感知养分的可用性。在效应子结合后,Cody能够结合并抑制其DNA靶标。尚不确定Cody中哪种氨基酸对于与这些效应子的相互作用是必需的,并且尚不清楚效应子结合如何改变Cody与DNA相互作用。该项目的目的是解决这两个基本问题。由于已经显示Cody调节了几种细菌病原体中毒力因子的表达,因此它是新型抗菌治疗的有吸引力的靶标。但是,这种治疗方案的发展将需要检查有关Cody活动的这些基本问题。该应用的第一个目的将鉴定出对效应子结合必不可少的氨基酸。同源性搜索和X射线晶体学研究产生了一些线索,即哪些Cody残基对GTP和BCAA结合可能很重要。这些残基将被诱变,并确定它们对效应子结合的影响。该应用的第二个目的将研究效应子结合如何增加Cody对DNA的亲和力。部分蛋白水解表明,在与BCAA结合时,Cody发生了构象变化,但是在Cody与GTP结合时未观察到变化。将使用近紫外圆形二角运动,光谱荧光测定法和傅立叶变换红外光谱法来确定GTP是否引起了Cody的第三级结构的细微改变。第三个目标中的实验将评估Cody效应子结合对基因表达的丧失的生理影响。这些Cody突变将引入枯草芽孢杆菌染色体,并将通过记者融合实验和微阵列分析来测定它们的作用。这项工作的结果将使我们能够理解细菌如何响应营养饥饿的基因表达。这种调节的破坏可能会导致一种新的细菌感染治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LUKE D HANDKE其他文献
LUKE D HANDKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LUKE D HANDKE', 18)}}的其他基金
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Optical platform for functional longitudinal imaging of metabolite uptake in vivo
用于体内代谢物摄取功能纵向成像的光学平台
- 批准号:
10585764 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
DeADP-ribosylation of host targets mediated by a bacterial effector
由细菌效应子介导的宿主靶标的 DeADP-核糖基化
- 批准号:
10667971 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别: